Management consultancy – M&A advisory, IT transformation and project management

Key Highlights:

– Through its innovative approach and focus on creative problem solving, the company has successfully delivered a multitude of complex projects and is renowned as a trusted partner amongst clients.

– Predominantly operates in the life sciences market, with clients including multinational organisations that operate within the healthcare, medical device and pharma spaces.

– Maintains strong, direct relationships with clients, several of which span over three years, and operates on an international basis, delivering global projects across 80+ countries.

– Long-standing, diverse and highly skilled London-based workforce in place, with the Company’s continued investment in the development of its team contributing to its excellent retention rates.

– The company has a London-based team that operates with a flexible working arrangement and meeting regularly at an office based in Central London. Teams also work from client locations, as required.

– 3-year relationships with major clients

– 100% of clients provide repeat business

Financial Highlights:

– Achieved turnover of circa £1.6 million in YE24, with an adjusted EBITDA of £609k.

– Turnover is projected to rise to £2.1 million in YE25, with adjusted EBITDA also expected to rise to £820k.

– Further projections for YE26 show a turnover of £2.8 million, with an adjusted EBITDA of £1.1 million.

– Maintains strong gross profit and adjusted EBITDA margins, averaging 60% and 36%, respectively, across the last two years.

– The enduring strength of the life sciences market, combined with the company’s demonstrable capabilities and increasing prominence, ensures that future revenue is secure, as the business continues to experience consistent, year-on-year growth alongside its clients.

– Strong pipeline in place for the coming year, having secured ongoing contracts with a number of high-value clients.